Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00951717 · ClinicalTrials.gov registry record · NA

Using a Preparation and Education Intervention to Reduce Postpartum Depression Among New Mothers (The MADE IT 2 Study)

A NA study of Depression and Depression, Postpartum, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
590
Enrollment target
1
Study location

NCT00951717 is a NA study of Depression and Depression, Postpartum that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 590 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00951717, a NA study of Depression and Depression, Postpartum, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
590 participants
Enrollment target
1
Study location

Study Summary

This study will test an intervention that aims to prevent postpartum depression by providing new mothers with information on and resources for dealing with the disorder.

Interventions

  • BEHAVIORAL Behavioral education intervention

Study Locations (1)

New York

  • Mount Sinai Hospital - New York

Trial Details

FieldValue
Enrollment Target 590 participants
Start Date 2009-07
Est. Completion 2010-10
Phase NA

What the Registry Record Tells You About NCT00951717

The ClinicalTrials.gov registry entry for NCT00951717 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 590 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 679 other Depression trials with a reported enrollment target (25% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Behavioral education intervention is the first listed.

NCT00951717 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00951717 about?

NCT00951717 is a clinical study titled "Using a Preparation and Education Intervention to Reduce Postpartum Depression Among New Mothers (The MADE IT 2 Study)". This study will test an intervention that aims to prevent postpartum depression by providing new mothers with information on and resources for dealing with the disorder.

What is the current status of trial NCT00951717?

This trial is currently completed. It is a NA study. The enrollment target is 590 participants. The study started on 2009-07. Estimated completion is 2010-10.

What conditions does trial NCT00951717 study?

This clinical trial studies the following conditions: Depression, Depression, Postpartum.

What interventions are being tested in trial NCT00951717?

The interventions under investigation include: Behavioral education intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00951717?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00951717 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.